WuXi PharmaTech (Cayman) Inc. upgraded to “Conviction-Buy” at Goldman Sachs (WX)

WuXi PharmaTech (Cayman) Inc. (ADR) logoWuXi PharmaTech (Cayman) Inc. (NYSE:WX) was upgraded by research analysts at Goldman Sachs from a “neutral” rating to a “conviction-buy” rating in a report released on Tuesday, TheFlyOnTheWall.com reports. WuXi PharmaTech (NYSE:WX) opened at 33.88…